Your browser doesn't support javascript.
loading
Autosomal Recessive Cerebellar Atrophy and Spastic Ataxia in Patients With Pathogenic Biallelic Variants in GEMIN5.
Rajan, Deepa S; Kour, Sukhleen; Fortuna, Tyler R; Cousin, Margot A; Barnett, Sarah S; Niu, Zhiyv; Babovic-Vuksanovic, Dusica; Klee, Eric W; Kirmse, Brian; Innes, Micheil; Rydning, Siri Lynne; Selmer, Kaja K; Vigeland, Magnus Dehli; Erichsen, Anne Kjersti; Nemeth, Andrea H; Millan, Francisca; DeVile, Catherine; Fawcett, Katherine; Legendre, Adrien; Sims, David; Schnekenberg, Ricardo Parolin; Burglen, Lydie; Mercier, Sandra; Bakhtiari, Somayeh; Francisco-Velilla, Rosario; Embarc-Buh, Azman; Martinez-Salas, Encarnacion; Wigby, Kristen; Lenberg, Jerica; Friedman, Jennifer R; Kruer, Michael C; Pandey, Udai Bhan.
Afiliación
  • Rajan DS; Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
  • Kour S; Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
  • Fortuna TR; Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
  • Cousin MA; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, MN, United States.
  • Barnett SS; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.
  • Niu Z; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Babovic-Vuksanovic D; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Klee EW; Department of Clinical Genomics, Mayo Clinic, Rochester, MN, United States.
  • Kirmse B; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, MN, United States.
  • Innes M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Rydning SL; Department of Clinical Genomics, Mayo Clinic, Rochester, MN, United States.
  • Selmer KK; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, MN, United States.
  • Vigeland MD; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.
  • Erichsen AK; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Nemeth AH; Department of Clinical Genomics, Mayo Clinic, Rochester, MN, United States.
  • Millan F; Division of Genetics, University of Mississippi Medical Center, Jackson, MS, United States.
  • DeVile C; Department of Medical Genetics and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Fawcett K; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Legendre A; Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital and the University of Oslo, Oslo, Norway.
  • Sims D; Department of Medical Genetics, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Schnekenberg RP; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
  • Burglen L; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Mercier S; GeneDx, Gaithersburg, MD, United States.
  • Bakhtiari S; Great Ormond Street Hospital, London, United Kingdom.
  • Francisco-Velilla R; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Embarc-Buh A; Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
  • Martinez-Salas E; Laboratoire de biologie médicale multisites Seqoia-FMG2025, Paris, France.
  • Wigby K; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Lenberg J; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Friedman JR; Centre de Référence des Malformations et Maladies Congénitales du Cervelet et Laboratoire de Neurogénétique Moléculaire, Département de Génétique, AP-HP. Sorbonne Université, Hôpital Trousseau, Paris, France.
  • Kruer MC; Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris, France.
  • Pandey UB; CHU Nantes, Service de génétique médicale, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Nantes, France.
Front Cell Dev Biol ; 10: 783762, 2022.
Article en En | MEDLINE | ID: mdl-35295849
ABSTRACT
The hereditary ataxias are a heterogenous group of disorders with an increasing number of causative genes being described. Due to the clinical and genetic heterogeneity seen in these conditions, the majority of such individuals endure a diagnostic odyssey or remain undiagnosed. Defining the molecular etiology can bring insights into the responsible molecular pathways and eventually the identification of therapeutic targets. Here, we describe the identification of biallelic variants in the GEMIN5 gene among seven unrelated families with nine affected individuals presenting with spastic ataxia and cerebellar atrophy. GEMIN5, an RNA-binding protein, has been shown to regulate transcription and translation machinery. GEMIN5 is a component of small nuclear ribonucleoprotein (snRNP) complexes and helps in the assembly of the spliceosome complexes. We found that biallelic GEMIN5 variants cause structural abnormalities in the encoded protein and reduce expression of snRNP complex proteins in patient cells compared with unaffected controls. Finally, knocking out endogenous Gemin5 in mice caused early embryonic lethality, suggesting that Gemin5 expression is crucial for normal development. Our work further expands on the phenotypic spectrum associated with GEMIN5-related disease and implicates the role of GEMIN5 among patients with spastic ataxia, cerebellar atrophy, and motor predominant developmental delay.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article